BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 24992040)

  • 1. The role of CXCR3 in DSS-induced colitis.
    Chami B; Yeung AW; van Vreden C; King NJ; Bao S
    PLoS One; 2014; 9(7):e101622. PubMed ID: 24992040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CXCL10+ T cells and NK cells assist in the recruitment and activation of CXCR3+ and CXCL11+ leukocytes during Mycobacteria-enhanced colitis.
    Singh UP; Singh R; Singh S; Karls RK; Quinn FD; Taub DD; Lillard JW
    BMC Immunol; 2008 Jun; 9():25. PubMed ID: 18533024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The simultaneous blockade of chemokine receptors CCR2, CCR5 and CXCR3 by a non-peptide chemokine receptor antagonist protects mice from dextran sodium sulfate-mediated colitis.
    Tokuyama H; Ueha S; Kurachi M; Matsushima K; Moriyasu F; Blumberg RS; Kakimi K
    Int Immunol; 2005 Aug; 17(8):1023-34. PubMed ID: 16000328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type I interferons have opposing effects during the emergence and recovery phases of colitis.
    Rauch I; Hainzl E; Rosebrock F; Heider S; Schwab C; Berry D; Stoiber D; Wagner M; Schleper C; Loy A; Urich T; Müller M; Strobl B; Kenner L; Decker T
    Eur J Immunol; 2014 Sep; 44(9):2749-60. PubMed ID: 24975266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of IL-17A in the pathogenesis of DSS-induced colitis in mice.
    Ito R; Kita M; Shin-Ya M; Kishida T; Urano A; Takada R; Sakagami J; Imanishi J; Iwakura Y; Okanoue T; Yoshikawa T; Kataoka K; Mazda O
    Biochem Biophys Res Commun; 2008 Dec; 377(1):12-6. PubMed ID: 18796297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophagic HDAC3 inhibition ameliorates Dextran Sulfate Sodium induced inflammatory bowel disease through GBP5-NLRP3 pathway.
    Che N; Zhang Y; Zhang S; Kong X; Zhang Y; Wang S; Yuan Z; Liao Y
    Int J Med Sci; 2024; 21(8):1385-1398. PubMed ID: 38903915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cux1 transcription factor is induced in inflammatory bowel disease and protects against experimental colitis.
    Darsigny M; St-Jean S; Boudreau F
    Inflamm Bowel Dis; 2010 Oct; 16(10):1739-50. PubMed ID: 20848487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MD-1 deficiency attenuates dextran sodium sulfate (DSS)-induced colitis through modulating the function of colonic lamina propria dendritic cells.
    Pan H; Zhang G; Zhang L; Wang W; Shang J; Wang X; Zhao Q; Li J
    Mol Immunol; 2016 Jul; 75():1-10. PubMed ID: 27209086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MANF ameliorates DSS-induced mouse colitis via restricting Ly6C
    Yang L; Shen WW; Shao W; Zhao Q; Pang GZ; Yang Y; Tao XF; Zhang WP; Mei Q; Shen YX
    Acta Pharmacol Sin; 2023 Jun; 44(6):1175-1190. PubMed ID: 36635421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
    Pedersen G
    Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GPR65 (TDAG8) inhibits intestinal inflammation and colitis-associated colorectal cancer development in experimental mouse models.
    Marie MA; Sanderlin EJ; Satturwar S; Hong H; Lertpiriyapong K; Donthi D; Yang LV
    Biochim Biophys Acta Mol Basis Dis; 2022 Jan; 1868(1):166288. PubMed ID: 34628032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deficiency of Protein Tyrosine Phosphatase Non-Receptor Type 2 in Intestinal Epithelial Cells Has No Appreciable Impact on Dextran Sulphate Sodium Colitis Severity But Promotes Wound Healing.
    Kasper SH; Spalinger MR; Leonardi I; Gerstgrasser A; Raselli T; Gottier C; Atrott K; Frey-Wagner I; Fischbeck-Terhalle A; Rogler G; Scharl M
    Digestion; 2016; 93(4):249-59. PubMed ID: 27115526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunobiotic
    Sato N; Garcia-Castillo V; Yuzawa M; Islam MA; Albarracin L; Tomokiyo M; Ikeda-Ohtsubo W; Garcia-Cancino A; Takahashi H; Villena J; Kitazawa H
    Front Immunol; 2020; 11():2174. PubMed ID: 33042131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The oxysterol receptor LXRβ protects against DSS- and TNBS-induced colitis in mice.
    Jakobsson T; Vedin LL; Hassan T; Venteclef N; Greco D; D'Amato M; Treuter E; Gustafsson JÅ; Steffensen KR
    Mucosal Immunol; 2014 Nov; 7(6):1416-28. PubMed ID: 24803164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FGL2 regulates IKK/NF-κB signaling in intestinal epithelial cells and lamina propria dendritic cells to attenuate dextran sulfate sodium-induced colitis.
    Li T; Chen RR; Gong HP; Wang BF; Wu XX; Chen YQ; Huang ZM
    Mol Immunol; 2020 Jan; 117():84-93. PubMed ID: 31743856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppressor of cytokine signaling-1 ameliorates dextran sulfate sodium-induced colitis in mice.
    Horino J; Fujimoto M; Terabe F; Serada S; Takahashi T; Soma Y; Tanaka K; Chinen T; Yoshimura A; Nomura S; Kawase I; Hayashi N; Kishimoto T; Naka T
    Int Immunol; 2008 Jun; 20(6):753-62. PubMed ID: 18381351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action.
    Yousef M; Pichyangkura R; Soodvilai S; Chatsudthipong V; Muanprasat C
    Pharmacol Res; 2012 Jul; 66(1):66-79. PubMed ID: 22475725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-21 knockout improve the survival rate in DSS induced fatal colitis through protecting against inflammation and tissue injury.
    Shi C; Liang Y; Yang J; Xia Y; Chen H; Han H; Yang Y; Wu W; Gao R; Qin H
    PLoS One; 2013; 8(6):e66814. PubMed ID: 23826144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental colitis in IL-10-deficient mice ameliorates in the absence of PTPN22.
    Jofra T; Galvani G; Cosorich I; De Giorgi L; Annoni A; Vecchione A; Sorini C; Falcone M; Fousteri G
    Clin Exp Immunol; 2019 Sep; 197(3):263-275. PubMed ID: 31194881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel Toll-like receptor 4 antagonist antibody ameliorates inflammation but impairs mucosal healing in murine colitis.
    Ungaro R; Fukata M; Hsu D; Hernandez Y; Breglio K; Chen A; Xu R; Sotolongo J; Espana C; Zaias J; Elson G; Mayer L; Kosco-Vilbois M; Abreu MT
    Am J Physiol Gastrointest Liver Physiol; 2009 Jun; 296(6):G1167-79. PubMed ID: 19359427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.